content top

CLEAR-IT 1: A Phase I Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients with Neovascular AMD

http://www.evrs.eu/medias/2006/congress/CLEAR-IT-1:-A-Phase-I-Safety,-Tolerability,-and-Bioactivity-Study-of-Intravitreal-VEGF-Trap-in-Patients-with-Neovascular-AMD.swf Quan Dong Nguyen, MD (Baltimore, MD),* David Browning, MD, PhD (Charlotte, NC),* Peter L. Sonkin, MD (Nashville, TN),* Seenu Hariprasad, MD (Chicago, IL),* Henry L. Hudson, MD, FACS (Tucson, AZ),* Karen Chu, (Tarrytown, NY),* Julia A. Haller, MD (Baltimore, MD), William F....

Read More

Two-year Phase II/III Results (IMT002) of a Visual Prosthesis for Treatment of Central Vision Loss Due to End-stage Macular Degeneration

http://www.evrs.eu/medias/2006/congress/Two-year-Phase-II-III-Results-(IMT002)-of-a-Visual-Prosthesis-for-Treatment-of-Central-Vision-Loss-Due-to-End-stage-Macular-Degeneration.swf Henry L. Hudson, MD, FACS (Tucson, AZ)* PURPOSE: To evaluate the safety and efficacy of an implantable telescope in patients with bilateral visual impairment due to end-stage age-related macular degeneration (AMD). The device is designed to improve visual acuity...

Read More
content top